EFFECTS OF POTASSIUM-ENRICHED SALT ON PRE-HYPERTENSIVE PATIENTS ATTENDING UNIVERSITY OF ABUJA TEACHING HOSPITAL, GWAGWALADA-NIGERIA

Elevated blood pressure is an important risk factor for hypertension and cardiovascular complications. Potassium-enriched salt substitutes may help to reduce blood pressure by lowering sodium intake while increasing potassium consumption. This study assessed the effects of potassium-enriched salt on blood pressure, serum electrolytes, renal and liver function, and acceptability among pre-hypertensive patients attending University of Abuja Teaching Hospital (UATH), Gwagwalada. A quasi-experimental one-group pre-test and post-test design was adopted. Forty-two (42) participants aged 18–60 years were enrolled, of whom thirty-eight (38) participants completed the eight-week intervention. Participants replaced regular salt with a potassium-enriched salt containing 66% potassium chloride and 34% sodium chloride. Blood pressure, serum electrolytes, renal and liver function were assessed before and after the intervention. Data were analyzed using descriptive statistics and paired t-test in SPSS version 31, with statistical significance set at p < 0.05. The results show that systolic and diastolic blood pressure decreased significantly following the intervention (p < 0.001). Serum sodium decreased from 145.74 ± 2.06 to 139.47 ± 1.93 mmol/L, while serum potassium increased from 3.01 ± 0.10 to 3.87 ± 0.28 mmol/L (p < 0.001). Serum chloride decreased significantly (p = 0.036), whereas bicarbonate showed no significant change (p = 0.184). Urea and creatinine showed no significant changes. Aspartate aminotransferase decreased significantly (p < 0.001), while albumin increased significantly (p = 0.039); other liver parameters showed no significant changes. Overall, 68.4% of participants accepted the potassium-enriched salt. Potassium-enriched salt was associated with significant reductions in blood pressure and favorable changes in serum sodium and potassium, with no significant changes in renal function over the eight-week intervention. The study concluded that potassium-enriched salt is effective, safe and acceptable dietary intervention for reducing blood pressure among pre-hypertensive patients. The healthcare providers should promote the use of potassium-enriched salt for prevention as the intervention was acceptable to most participants in the study.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-13
DOI
https://doi.org/10.5281/zenodo.23340575
Primary Topic
Sodium Intake and Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EFFECTS OF POTASSIUM-ENRICHED SALT ON PRE-HYPERTENSIVE PATIENTS ATTENDING UNIVERSITY OF ABUJA TEACHING HOSPITAL, GWAGWALADA-NIGERIA

FD Tarfa, MS Audu, MA Daikwo
Zenodo (CERN European Organization for Nuclear Research)
Sodium Intake and Health
article

EFFECTS OF POTASSIUM-ENRICHED SALT ON PRE-HYPERTENSIVE PATIENTS ATTENDING UNIVERSITY OF ABUJA TEACHING HOSPITAL, GWAGWALADA-NIGERIA

FD Tarfa, MS Audu, MA Daikwo
article en

Abstract

Elevated blood pressure is an important risk factor for hypertension and cardiovascular complications. Potassium-enriched salt substitutes may help to reduce blood pressure by lowering sodium intake while increasing potassium consumption. This study assessed the effects of potassium-enriched salt on blood pressure, serum electrolytes, renal and liver function, and acceptability among pre-hypertensive patients attending University of Abuja Teaching Hospital (UATH), Gwagwalada. A quasi-experimental one-group pre-test and post-test design was adopted. Forty-two (42) participants aged 18–60 years were enrolled, of whom thirty-eight (38) participants completed the eight-week intervention. Participants replaced regular salt with a potassium-enriched salt containing 66% potassium chloride and 34% sodium chloride. Blood pressure, serum electrolytes, renal and liver function were assessed before and after the intervention. Data were analyzed using descriptive statistics and paired t-test in SPSS version 31, with statistical significance set at p < 0.05. The results show that systolic and diastolic blood pressure decreased significantly following the intervention (p < 0.001). Serum sodium decreased from 145.74 ± 2.06 to 139.47 ± 1.93 mmol/L, while serum potassium increased from 3.01 ± 0.10 to 3.87 ± 0.28 mmol/L (p < 0.001). Serum chloride decreased significantly (p = 0.036), whereas bicarbonate showed no significant change (p = 0.184). Urea and creatinine showed no significant changes. Aspartate aminotransferase decreased significantly (p < 0.001), while albumin increased significantly (p = 0.039); other liver parameters showed no significant changes. Overall, 68.4% of participants accepted the potassium-enriched salt. Potassium-enriched salt was associated with significant reductions in blood pressure and favorable changes in serum sodium and potassium, with no significant changes in renal function over the eight-week intervention. The study concluded that potassium-enriched salt is effective, safe and acceptable dietary intervention for reducing blood pressure among pre-hypertensive patients. The healthcare providers should promote the use of potassium-enriched salt for prevention as the intervention was acceptable to most participants in the study.

Zenodo (CERN European Organization for Nuclear Research)
Bingham University (NG)
Openalex Percentile: Top 13%
Sodium Intake and Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.